Goleta and the UC Regents have reached a settlement on the 2021 lawsuit in which the city alleged UC Santa Barbara was not building student and faculty housing as provided for in the university's 2010 long range development plan. Announced March 22, the city alleged that the lack of long range housing plans negatively impacted
Editor's note: This story was updated on Feb. 23 to include more info about the company's lead treatment. Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to
Jackpocket opened its Santa Barbara headquarters in 2021. (courtesy photo) Santa Barbara-based Jackpocket, a lottery courier software company, has reached an agreement to be purchased by DraftKings, one of the largest digital sports entertainment apps in the country, for approximately $750 million. Announced Feb. 15, 55% of the deal will be paid in cash with
Goleta-based Deckers saw shares jump up 14% on Feb. 2, one day after the company delivered record results during its third-quarter earnings release as well as the news that longtime President and CEO Dave Powers will be retiring on Aug. 1. According to a press release, Powers will still be serving on Deckers' board of
Westlake Village-based Arcutis Biotherapeutics announced that its main treatment option, Zoryve, received approval from the U.S. Drug and Food Administration for treating a skin condition called seborrheic dermatitis, the company announced on Dec. 15 It is the second FDA approval received by Arcutis’ Zoryve, being approved to be used in individuals nine years of age